Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Florida Cancer Specialists, Sarasota, Florida Columbia University Medical Center, New York, New York University Hospitals Cleveland Medical Center, Cleveland, Ohio United Kingdom
The Christie NHS Foundation Trust Christie Hospital, Manchester Royal Marsden Hospital, Sutton